Medical innovation should serve everyone, everywhere. Our founding motto, ‘Best Science for the Most Neglected’, remains our calling.
Foreword
2024 will be remembered as a year of geopolitical turbulence that also saw the beginnings of drastic cuts to global health programmes and assaults on international health cooperation.
We stand firmly with our allies working to resist these alarming threats and stand ready to work with countries confronting urgent new challenges with bolstered leadership and conviction.
2024 in numbers
in our R&D portfolio, and an additional 14 projects in the treatment access phase
in 7 disease areas, including 10 trials testing new chemical entities
enrolled in active DNDi clinical studies
of partner staff vs DNDi staff* worldwide
*Staff in full-time equivalents (FTEs)
represented among DNDi employees on 5 continents
DNDi WORLDWIDE
DNDi WORLDWIDE
Clinical sites
- Sleeping sickness
- Leishmaniasis
- Chagas disease
- Parasitic worms
- Mycetoma
- HIV
- Pandemic preparedness
R&D AND
ACCESS PARTNERS
DNDi OFFICES
FOUNDING PARTNERS- COUNTRIES WITH DNDi ACTIVITIES
OUR PROGRESS
RESEARCH & DEVELOPMENT PORTFOLIO
RESEARCH & DEVELOPMENT PORTFOLIO
Acting as a ‘conductor of a virtual orchestra’, we collaborate with research partners around the world at all stages of the R&D process.
Our R&D portfolio includes nine disease areas and 46 projects, 21 of which are focused on identifying or developing new chemical entities.
Performance
88% of 2024 DNDi expenditure was for our social mission across R&D and access, Capacity strengthening, Policy, and Advocacy & Communication
A WORD OF THANKS
DNDi has delivered 13 new treatments for six neglected diseases since 2003. We are deeply grateful to our partners and donors for their collaboration and support.
Photo credits: Lameck Ododo-DNDi; Brent Stirton/Getty Images; Neil Brandvold-DNDi; Xavier Vahed-DNDi; WHO/Violaine Martin; Felipe Abondano-DNDi; Thoko Chikondi-DNDi; Aliya Bashir/DNDi; Ley Uwera-DNDi; Fábio Nascimento-DNDi; FARMOVS/Vicky Simpson-DNDi; Abang Amirrul Hadi-DNDi
Stay connected
Get our latest news, personal stories, research articles, and job opportunities.
